Clinical Trial Update: Efficacy and Safety of Ofatumumab Retreatment and Maintenance Treatment in Patients With B-cell Chronic Lymphocytic Leukemia (CLL) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated retreatment and maintenance therapy with ofatumumab in patients with chronic lymphocytic leukemia, with results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Ofatumumab (ofatumumab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Leukaemia, Lymphocytic, Chronic | Phase 4 | Status: COMPLETED | Results posted: 2012-06-26